68 Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177 Lu-PSMA-617

Conclusion68Ga-PSMA PET/CT appears to have added value in patients with RAI-refractory DTC, as it is able to detect various types of lesions, some of which were not picked up by18FDG PET/CT. Furthermore,68Ga-PSMA PET/CT might be used to identify patients eligible for treatment with177Lu-PSMA-617. One of the two patients who underwent177Lu-PSMA-617 therapy showed a modest, temporary response. To draw conclusions about the effectiveness of this therapy, more research is needed.
Source: EJNMMI Research - Category: Radiology Source Type: research